| Detected | Trial | Change |
|---|---|---|
| 2026-08-07 | NCT07717736 Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment… |
Primary endpoint(s) modified |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-21 | NCT07717736 Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment… | Phase 4 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07717736 | Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment… | Epidermolysis Bullosa (EB) | Not Yet Recruiting |
| Phase 3 | |||
| NCT05725018 | A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and… | Epidermolysis Bullosa | Active, Not Recruiting |
| Not specified | |||
| NCT07700966 | A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With… | Recessive Dystrophic Epidermolysis Bullosa | Recruiting |
| NCT05708677 | A Long-Term Extension Study for Participants Previously Treated With EB-101 for the… | RDEB | Enrolling by Invitation |